- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
99
5 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
99 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300181 | CN¥14.57 | -1.8% | 43.4% | CN¥10.0b | CN¥23.00 | PE19.3x | E23.3% | 3.1% | ||
300363 | CN¥17.30 | 0.3% | -7.5% | CN¥9.4b | CN¥20.00 | PS3.4x | E123.9% | 2.8% | ||
BFRI | US$1.18 | 2.6% | 57.4% | US$9.1m | US$11.50 | PS0.3x | E61.3% | n/a | ||
AELIS | €2.36 | 6.3% | -82.3% | €32.1m | €9.10 | PS3x | E33.8% | n/a | ||
688217 | CN¥22.70 | 7.8% | -5.2% | CN¥1.3b | n/a | PS5x | E62.5% | 0.8% | ||
9995 | HK$15.62 | 8.0% | -19.7% | HK$14.4b | HK$25.04 | PS5.1x | E51.9% | n/a | ||
6919 New | NT$942.00 | 11.5% | 256.1% | NT$144.5b | NT$930.00 | PS3252.9x | E109.9% | n/a | ||
MEDCL | €14.00 | -11.4% | 59.1% | €409.2m | €23.17 | PS31x | E114.3% | n/a | ||
SENZA | SEK 6.30 | -11.9% | -4.5% | SEK 185.9m | SEK 14.50 | PS3.2x | E129.9% | n/a | ||
A228760 | ₩17,800.00 | 4.5% | -3.2% | ₩427.0b | n/a | PS194.1x | E115.9% | n/a | ||
688293 | CN¥42.62 | 8.8% | 4.1% | CN¥4.8b | n/a | PE125.9x | E62.6% | 1.1% | ||
NRXP | US$2.85 | -3.1% | -39.5% | US$34.4m | US$31.67 | PE-1.7x | E58.8% | n/a | ||
603520 | CN¥8.78 | 4.3% | -5.0% | CN¥3.8b | CN¥10.65 | PE277.1x | E88.7% | 1.1% | ||
A298380 | ₩39,500.00 | 0.1% | 93.6% | ₩1.9t | ₩48,750.00 | PS59x | E38.0% | n/a | ||
ARX | AU$0.56 | 0.9% | -1.8% | AU$191.4m | AU$0.85 | PS2.8x | E60.4% | n/a | ||
603392 | CN¥68.53 | 1.0% | 9.2% | CN¥86.7b | CN¥61.40 | PS34.8x | E109.4% | 0.5% | ||
688105 | CN¥21.71 | 2.7% | -14.4% | CN¥8.6b | CN¥24.65 | PE365.8x | E90.0% | 0.3% | ||
BRTX | US$2.29 | -0.4% | 53.7% | US$15.8m | US$13.00 | PS42x | E64.1% | n/a | ||
TLSI | US$5.65 | 1.4% | -37.6% | US$172.3m | US$11.44 | PS6.4x | E60.4% | n/a | ||
DXRX New | UK£1.39 | 3.0% | 41.1% | UK£117.5m | UK£1.99 | PS4.5x | E63.9% | n/a | ||
ORY | €1.68 | 12.9% | -10.6% | €108.6m | €6.17 | PS7.2x | E52.2% | n/a | ||
KRYS | US$153.24 | -1.1% | 34.9% | US$4.4b | US$206.25 | PE84.2x | E36.6% | n/a | ||
LQDA | US$16.20 | 2.9% | 11.0% | US$1.4b | US$25.33 | PS87.8x | E57.4% | n/a | ||
6185 | HK$32.90 | 9.3% | 89.7% | HK$12.1b | HK$32.68 | PS10.1x | E128.6% | 0% |